More on CRSP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (5.4 Score)
- Holders

Upcoming Events

- Earnings (11/4/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CRISPR Therapeutics (NQ:CRSP)
Delayed: 49.39 -0.6 (1.2%)
Prev. Close $49.99  
Open$49.31 
52 Wk High$18.88 
52 Wk Low$13.75 
Day High$49.68 
Day Low$48.02 
P/E N/A  
EPS$0.00 
Volume2,120,007 

Friends, Peers and Foes (?): NTLA, DNTH, ARWR, AGMB, BEAM (more...)

Oct 21, 2026 05:42 PM Form 4 CRISPR Therapeutics AG For: Oct 19 Filed by: Silver Andrew Jacob
Oct 21, 2026 05:36 PM Form 3 CRISPR Therapeutics AG For: Oct 19 Filed by: Silver Andrew Jacob
Oct 20, 2026 05:35 PM Form 4 CRISPR Therapeutics AG For: Oct 16 Filed by: Kulkarni Samarth
Oct 19, 2026 04:11 PM Form 8-K CRISPR Therapeutics AG For: Oct 19
Oct 19, 2026 04:05 PM CRISPR Therapeutics names A.J. Silver as new CFO
Oct 19, 2026 04:05 PM CRISPR Therapeutics Announces Chief Financial Officer Transition
Oct 16, 2026 05:46 PM Form 4 CRISPR Therapeutics AG For: Oct 14 Filed by: George Simeon
Oct 15, 2026 05:35 PM Form 4 CRISPR Therapeutics AG For: Oct 13 Filed by: KASINGER JAMES R.
Oct 15, 2026 05:35 PM Form 4 CRISPR Therapeutics AG For: Oct 13 Filed by: Kulkarni Samarth
Oct 14, 2026 04:45 PM UBS Starts CRISPR Therapeutics (CRSP) at Neutral
View All Articles

Entities mentioned with CRSP

View All Entities